Compare Lustrum:Cyfuse Biomedical K.K.:4892

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Cyfuse Biomedical K.K. 4892 Medicals 東証グロース December 1, 2000 2022.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

Cyfuse Biomedical K.K. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Cyfuse Biomedical K.K. Balance Sheet 2023年12月期 Cyfuse Biomedical K.K. Balance Sheet 2022年12月期 Cyfuse Biomedical K.K. Balance Sheet 2021年12月期 Cyfuse Biomedical K.K. Balance Sheet 2020年12月期 Cyfuse Biomedical K.K. Balance Sheet 年0月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Cash and Cash Equivalents
(Percent)
3,874down
(91.9%)down
4,437up
(92.1%)up
2,413up
(91.2%)down
2,073
(94.4%)

-
Other Current AssetsHelp
(Percent)
114down
(2.7%)up
128down
(2.7%)down
146up
(5.5%)up
79
(3.6%)

-
Tangible Fixed AssetsHelp
(Percent)
170down
(4.0%)up
189up
(3.9%)up
27down
(1.0%)down
33
(1.5%)

-
Intangible Fixed AssetHelp
(Percent)
4down
(0.1%)down
5up
(0.1%)down
5down
(0.2%)down
6
(0.3%)

-
Investments and OthersHelp
(Percent)
53down
(1.3%)up
55down
(1.2%)down
56up
(2.1%)up
6
(0.3%)

-
Total AssetsHelp
(Percent)
4,215
(100%)
4,815
(100%)
2,646
(100%)
2,196
(100%)
-
(100%)
Total Current LiabilitiesHelp
(Percent)
666down
(15.8%)up
683up
(14.2%)down
386up
(14.6%)up
207
(9.4%)

-
Total Long-term LiabilitiesHelp
(Percent)
345down
(8.2%)up
363up
(7.5%)down
360down
(13.6%)down
440
(20.0%)

-
Shareholder's EquityHelp
(Percent)
3,203down
(76.0%)down
3,770up
(78.3%)up
1,900up
(71.8%)up
1,549
(70.6%)

-
Total LiabilitiesHelp
(Percent)
4,215
(100%)
4,815
(100%)
2,646
(100%)
2,196
(100%)
-
(100%)

Cyfuse Biomedical K.K. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Cyfuse Biomedical K.K. Profit and Loss Account 2023年12月期 Cyfuse Biomedical K.K. Profit and Loss Account 2022年12月期 Cyfuse Biomedical K.K. Profit and Loss Account 2021年12月期 Cyfuse Biomedical K.K. Profit and Loss Account 2020年12月期 Cyfuse Biomedical K.K. Profit and Loss Account 年0月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Amount of Sales
(Percent)
61
(100%)
374
(100%)
708
(100%)
137
(100%)
-
(100%)
Total Sales
(Percent)
61
(100%)
374
(100%)
708
(100%)
137
(100%)
-
(100%)
Cost of SalesHelp
(Percent)
23down
(38.2%)up
133down
(35.5%)up
138up
(19.4%)down
70
(51.3%)

-
Other Costs and RevenueHelp 627down
(1,025.9%)up
715up
(191.1%)up
428up
(60.4%)down
397
(288.4%)

-
Total CostsHelp 650 848 565 467 -
Net RevenueHelp 38down
(61.8%)down
241down
(64.5%)down
571up
(80.6%)up
67
(48.7%)

-
Earnings Before TaxHelp -586down
(-959.2%)down
-472down
(-126.0%)down
145up
(20.5%)up
-327
(-238.2%)

-
Net IncomeHelp -589down
(-964.1%)down
-474down
(-126.6%)down
143up
(20.2%)up
-330
(-239.7%)

-
当期純利益 -589 -474 143 -330 -

Cyfuse Biomedical K.K. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Cyfuse Biomedical K.K. Cash Flow Statement 2023年12月期 Cyfuse Biomedical K.K. Cash Flow Statement 2022年12月期 Cyfuse Biomedical K.K. Cash Flow Statement 2021年12月期 Cyfuse Biomedical K.K. Cash Flow Statement 2020年12月期 Cyfuse Biomedical K.K. Cash Flow Statement 年0月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Operating Cash Flow(OFC)Help
(Percent)
-562down
(-96.7%)down
-404down
(-15.2%)down
162up
(41.3%)up
-294
(-60.1%)

-
Investing Cash Flow(ICF)Help
(Percent)
-19up
(-3.3%)up
-431down
(-16.2%)down
-51down
(-12.9%)down
-0
(-0.1%)

-
Financing Cash FlowHelp
(Percent)
18down
(3.1%)down
2,659up
(100.0%)up
229down
(58.7%)down
489
(100.0%)

-
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)
0
(0.0%)
0
-
0
-
0
(0.0%)

-
Net Increase and Decrease in Cash and Cash Equivalentsn -564down
(-96.9%)down
1,824up
(68.6%)down
340up
(87.1%)up
195
(39.8%)

-

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Cyfuse Biomedical K.K.

Company where related level is highHelp

ECI,Inc.
TAIKO PHARMACEUTICAL CO.,LTD.
Mochida Pharmaceutical Co.,Ltd.
StemRIM Inc.
Sumitomo Pharma Co., Ltd.
ASKA Pharmaceutical Holdings Co., Ltd.
Modalis Therapeutics Corporation
Perseus Proteomics Inc.
Oncolys BioPharma Inc.
MIZUHO MEDY CO.,LTD.